Free Trial

Cingulate (CINGW) Competitors

$0.12 -0.02 (-16.48%)
As of 08/5/2025 03:32 PM Eastern

CINGW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

Cingulate vs. Its Competitors

Cingulate (NASDAQ:CINGW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, 180 Life Sciences had 1 more articles in the media than Cingulate. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Cingulate. 180 Life Sciences' average media sentiment score of 0.95 beat Cingulate's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Cingulate Neutral
180 Life Sciences Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

180 Life Sciences beats Cingulate on 2 of the 2 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

MetricCingulateBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$137.01M$5.59B$9.53B
Dividend YieldN/A3.74%4.73%4.14%
P/E RatioN/A3.7528.9123.88
Price / SalesN/A4,302.40448.7998.82
Price / CashN/A13.1935.6858.35
Price / BookN/A39.278.165.60
Net IncomeN/A-$90.99M$3.25B$265.26M
7 Day Performance-4.08%-0.82%1.15%-0.14%
1 Month PerformanceN/A4.14%8.25%6.08%
1 Year PerformanceN/A179.01%29.18%24.22%

Cingulate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.12
-16.5%
N/A+1,285.6%$0.00N/A0.0020Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-13.6%
N/A+38.2%$0.00N/A0.007Gap Up
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/A-74.2%$0.00N/A0.002
AIMDW
Ainos
N/A$0.12
flat
N/A+57.3%$0.00$106.21K0.0040Positive News
Gap Down
ALVOW
Alvotech
N/A$1.60
-17.5%
N/A-41.2%$0.00$585.60M0.004Positive News
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
-0.6%
N/A-24.8%$0.00N/A0.0015High Trading Volume
BFRIW
Biofrontera
N/A$0.15
-16.7%
N/A+214.7%$0.00$38.00M0.0070Positive News
Gap Down
BTMDW
biote
N/A$0.02
+45.7%
N/A-99.0%$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.04
-19.6%
N/A-79.9%$0.00N/A0.008Positive News
Short Interest ↑
Gap Up

Related Companies and Tools


This page (NASDAQ:CINGW) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners